SEGMENT REPORTING (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

The following table reflects results of operations of the Company’s reportable segment (in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2025		2024		2025		2024
Infusion services net revenue	$	1,393,008	$	1,205,561	$	2,704,189	$	2,331,223
Other revenue (1)	23,077		21,625		44,868		42,015
Total Option Care Health revenue	1,416,085		1,227,186		2,749,057		2,373,238
(Expense) Income:
Cost of net revenues - drugs	(1,004,610)		(847,420)		(1,937,678)		(1,624,680)
Salaries, benefits, and other employee expense	(212,195)		(193,298)		(417,887)		(385,113)
Other segment items (2)	(100,329)		(90,886)		(199,607)		(184,105)
Depreciation and amortization expense	(16,241)		(14,907)		(31,987)		(29,635)
Interest expense, net	(14,447)		(12,603)		(27,678)		(25,805)
Equity in earnings of joint ventures	1,395		1,405		3,124		2,530
Other, net	(797)		2,564		(4,927)		2,566
Income tax expense	(18,338)		(18,998)		(35,152)		(31,162)
Net Income	$	50,523	$	53,043	$	97,265	$	97,834

(1) Represents business activities related to other miscellaneous revenue streams.

(2) Other segment items includes expenses for medical supplies, delivery and packaging, leases, professional services, and other expenses.